Shuttle Pharmaceuticals Holdings, Inc. (SHPH): Nasdaq/NYSE listing notice — Shuttle Pharmaceuticals regains compliance with Nasdaq equity requirement after $2.5M private placement

Shuttle Pharmaceuticals Holdings, Inc.

Stockholders' equity was $1,394,161 on Sept 30, 2025, below Nasdaq's $2.5M minimum.
Company raised ~$2.5 million gross in a private placement on November 4, 2025.
Company believes it has regained compliance but Nasdaq will monitor ongoing compliance.
If next periodic report fails to show compliance, Company may be subject to delisting.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Shuttle Pharmaceuticals Holdings, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: stockholders equity
Rules: 5550(b)(1)

Exact text from the filing

or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. Shuttle Pharmaceuticals Holdings, Inc. (the “Company”) reported stockholders’ equity of $1,394,161 in its Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2025, and, as a result, was not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Shuttle Pharmaceuticals Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-25-023845

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.